SCHEMBL25916339

SCHEMBL25916339

O=C(Nc1cc(CI)ccc1-c1nc2ccccc2s1)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.59
MEN1 O00255 4/20 0.59
KMT2A Q03164 4/20 0.59
SMN1; SMN2 Q16637 4/20 0.59
HPGD P15428 3/20 0.59
ALDH1A1 P00352 3/20 0.59
NPC1 O15118 2/20 0.59
RAB9A P51151 2/20 0.59
KDM4E B2RXH2 1/20 0.59
MMP2 P08253 1/20 0.58
MMP9 P14780 1/20 0.58
MMP8 P22894 1/20 0.58
MMP13 P45452 1/20 0.58
TP53 P04637 4/20 0.54
RXFP1 Q9HBX9 4/20 0.53
USP2 O75604 1/20 0.53
TSHR P16473 1/20 0.53
MAPK1 P28482 1/20 0.53
ATM Q13315 1/20 0.53
HSD17B10 Q99714 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30362646 0.83 HPGD (0.78) MAPTMEN1KMT2ASMN1; SMN2HPGD
SCHEMBL25916294 0.83 HPGD (0.78) MAPTMEN1KMT2ASMN1; SMN2HPGD
SCHEMBL25916842 0.83 MAPT (0.66) MAPTMEN1KMT2ASMN1; SMN2HPGD
SCHEMBL30362693 0.83 MAPT (0.61) MAPTMEN1KMT2ASMN1; SMN2HPGD
SCHEMBL25916362 0.83 MAPT (0.61) MAPTMEN1KMT2ASMN1; SMN2HPGD
SCHEMBL30362804 0.80 MAPT (0.75) MAPTMEN1KMT2ASMN1; SMN2HPGD
SCHEMBL25916333 0.80 MAPT (0.75) MAPTMEN1KMT2ASMN1; SMN2HPGD
SCHEMBL25916758 0.79 MAPT (0.56) MAPTMEN1KMT2ASMN1; SMN2HPGD
SCHEMBL30362642 0.77 HPGD (0.62) MAPTMEN1KMT2ASMN1; SMN2HPGD
SCHEMBL30362567 0.77 HPGD (0.62) MAPTMEN1KMT2ASMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230235190-A1 FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS Crime Science Technology (FR) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230235190-A1 FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS TUBB3, TUBA3C, PHB1 MAPT 318/4885MEN1 1798/4885KMT2A 4267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.